
GC19070
LMT-28
Also known as (4S)-3-[(2S,3S)-3-hydroxy-2-methyl-4-methylidenenonanoyl]-4-propan-2-yl-1,3-oxazolidin-2-one
LMT-28 is an orally active and the first synthetic IL-6 inhibitor that functions through direct binding to gp130
ChemicalCAS1239600-18-0MW311.42FormulaC₁₇H₂₉NO₄
- CAS number
- 1239600-18-0
- Molecular weight
- 311.42
- Formula
- C₁₇H₂₉NO₄
- Solubility
- 100 mg/mL in DMSO (321·11 mM), < 0·1 mg/mL Water (insoluble)
- InChIKey
- UDXWSYOXIRPYFK-RRFJBIMHSA-N
- Catalogue number
- GC19070
- Brand
- GLPBIO
Computed properties PubChem CID 49846977 · XLogP 4.3 · TPSA 66.8 Ų · H-bond donors 1
- XLogP
- 4.3
- TPSA
- 66.8 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 8
- Heavy atoms
- 22
SMILES CCCCCC(=C)[C@H]([C@H](C)C(=O)N1[C@H](COC1=O)C(C)C)O
Computed descriptors from PubChem (CID 49846977), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il